Abstract | BACKGROUND: No studies have investigated the immediate impact of receiving an allogeneic hematopoietic stem cell transplant (HSCT) on pulmonary inflammation or lung function. METHODS: Using a prospective study design, we quantified the changes in these outcome measures in eligible adult individuals in the first six months after receiving an allogeneic hematopoietic stem cell transplant. RESULTS: Between January 2007 and December 2008, 72 patients were eligible to participate in the cohort, and of these 68 (94%) were included in the study. Compared to baseline, pulmonary inflammation as measured by exhaled nitric oxide increased after receiving a HSCT with the largest increment seen at three months (+6.0 ppb, 95%CI: +0.4 to +11.5), and this was sustained at six months. Percent predicted forced expiratory volume in one second decreased over the same period, with the largest decrease observed at six weeks (-5.9%, 95% CI: -8.9 to -2.9), and this was also sustained over a six month period. Similar associations were observed for FVC. A larger increase in exhaled nitric oxide from baseline at six weeks and three months may be associated with decreased mortality (p=0.06, p=0.04 respectively). CONCLUSION: Our data demonstrate that recipients of an allogeneic HSCT experience an increase in biomarkers of pulmonary inflammation and a decrease in lung function in the first six months after the procedure. If independently validated in other study populations, these observations could have potential as a prognostic biomarker for this patient group.
|
Authors | Alexandra Enocson, Richard Hubbard, Tricia McKeever, Nigel Russell, Jennifer Byrne, Emma Das-Gupta, Lynne Watson, Andrew W Fogarty |
Journal | BMC pulmonary medicine
(BMC Pulm Med)
Vol. 13
Pg. 2
(Jan 11 2013)
ISSN: 1471-2466 [Electronic] England |
PMID | 23311727
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
|
Topics |
- Acute Disease
- Adult
- Breath Tests
- Female
- Forced Expiratory Volume
(physiology)
- Hematologic Diseases
(mortality, therapy)
- Hematopoietic Stem Cell Transplantation
(adverse effects, mortality)
- Humans
- Lung
(immunology, physiology)
- Male
- Middle Aged
- Nitric Oxide
(metabolism)
- Pneumonia
(immunology, mortality, physiopathology)
- Predictive Value of Tests
- Proportional Hazards Models
- Prospective Studies
- Transplantation, Homologous
- Vital Capacity
(physiology)
|